Design of proteasome inhibitors with oral efficacy in vivo against Plasmodium falciparum and selectivity over the human proteasome (2021)
- Authors:
- USP affiliated authors: GUIDO, RAFAEL VICTÓRIO CARVALHO - IFSC ; AGUIAR, ANNA CAROLINE CAMPOS - IFSC
- Unidade: IFSC
- DOI: 10.1073/pnas.2107213118
- Subjects: PLASMODIUM FALCIPARUM; PLANEJAMENTO DE FÁRMACOS; MALÁRIA; QUÍMICA MÉDICA
- Keywords: Plasmodium; Proteasome; Antimalarial drug; Peptide boronate; Cryo-EM
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: Washington, DC
- Date published: 2021
- Source:
- Título: Proceedings of the National Academy of Sciences of the United States of America - PNAS
- ISSN: 0027-8424
- Volume/Número/Paginação/Ano: v. 118, n. 39, p. e2107213118-1-e2107213118-9, Aug. 2021
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
XIE, Stanley C. e AGUIAR, Anna Caroline Campos e GUIDO, Rafael Victorio Carvalho. Design of proteasome inhibitors with oral efficacy in vivo against Plasmodium falciparum and selectivity over the human proteasome. Proceedings of the National Academy of Sciences of the United States of America - PNAS, v. 118, n. 39, p. e2107213118-1-e2107213118-9, 2021Tradução . . Disponível em: https://doi.org/10.1073/pnas.2107213118. Acesso em: 11 fev. 2026. -
APA
Xie, S. C., Aguiar, A. C. C., & Guido, R. V. C. (2021). Design of proteasome inhibitors with oral efficacy in vivo against Plasmodium falciparum and selectivity over the human proteasome. Proceedings of the National Academy of Sciences of the United States of America - PNAS, 118( 39), e2107213118-1-e2107213118-9. doi:10.1073/pnas.2107213118 -
NLM
Xie SC, Aguiar ACC, Guido RVC. Design of proteasome inhibitors with oral efficacy in vivo against Plasmodium falciparum and selectivity over the human proteasome [Internet]. Proceedings of the National Academy of Sciences of the United States of America - PNAS. 2021 ; 118( 39): e2107213118-1-e2107213118-9.[citado 2026 fev. 11 ] Available from: https://doi.org/10.1073/pnas.2107213118 -
Vancouver
Xie SC, Aguiar ACC, Guido RVC. Design of proteasome inhibitors with oral efficacy in vivo against Plasmodium falciparum and selectivity over the human proteasome [Internet]. Proceedings of the National Academy of Sciences of the United States of America - PNAS. 2021 ; 118( 39): e2107213118-1-e2107213118-9.[citado 2026 fev. 11 ] Available from: https://doi.org/10.1073/pnas.2107213118 - Aryl benzimidazoles: a new lead in malaria drug discovery
- Potent antimalarials with development potential identified by structure-guided computational optimization of a pyrrole-based dihydroorotate dehydrogenase inhibitor series
- Repositioning and characterization of 1‑(Pyridin-4-yl)pyrrolidin-2- one derivatives as plasmodium cytoplasmic prolyl-tRNA synthetase inhibitors
- Fighting Plasmodium chloroquine resistance with acetylenic chloroquine analogues
- [1-7-NαC]-Crocaorb A1 and A2, orbitides from the latex of Croton campanulatus
- Preclinical characterization and target validation of the antimalarial pantothenamide MMV693183
- Descoberta de derivados de marinoquinolina como inibidores de Plasmodium falciparum
- Marinoquinolines as highly active and selective antimalarial compounds
- Estudo do efeito de um grupo espaçador metilênico em marinoquinolinas: síntese e avaliação biológica
- Descoberta de compostos novos híbridos de marinoquinolina com derivados de artemisinina como inibidores de plasmodium falciparum
Informações sobre o DOI: 10.1073/pnas.2107213118 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
3043707.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
